This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Investments

Oct. 22, 2011

Big pharma willing to invest in early stage technology, survey says

Pharmaceutical and large biotechnology companies are paying less to partner with small biotech firms, but they're willing to invest in early stage technology again, according to a Campbell Alliance survey presented to Biocom in San Diego.


By Mandy Jackson


Daily Journal Staff Writer


Pharmaceutical and large biotechnology companies are paying less to partner with smaller biotech firms, but the good news is that they're willing to invest in early-stage technology again.


The Campbell Alliance, a pharmaceutical consulting firm, delivered that news in its annual Dealmakers' Intentions Survey, which was discussed by Southern California biotech executives on Thursday during a m...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up